Carlos Quezada Ruiz, MD, Senior Medical Director, Clinical Science Product Development, Genentech

Carlos Quezada Ruiz, MD,

Carlos Quezada-Ruiz, M.D. is a Senior Medical Director on Genentech’s Ophthalmology Clinical Science team and a practicing retina specialist in Monterrey, Mexico. Carlos’ current work focuses on the advancement of new and better therapies for patients afflicted with retinal diseases around the world, including being the lead of the neovascular age related macular degeneration of the development of Roche and Genentech’s faricimab (formerly RG7716), the first bispecific antibody designed for retinal eye diseases, which is currently in Phase III clinical trials for the treatment of diabetic macular edema (DME) and for the treatment of wet age-related macular degeneration (AMD). Carlos is also the late stage lead for our Gene therapy efforts. In the past, Carlos also supported Lucentis and the development of Genentech’s Port Delivery System with ranibizumab (PDS) which is currently in a Phase III clinical trial.

Carlos is Retina Surgeon and a board-certified ophthalmologist by the ECFMG (Educational Commission for Foreign Medical Graduates), the International Council of Ophthalmology and the Mexican Council of Ophthalmology and specializes in the treatment of medical and surgical retinal diseases such as diabetic retinopathy, retinal vein occlusion, retinal detachment and AMD.

Carlos has authored several peer-reviewed publications and book chapters and serves as a peer reviewer and editorial board member for several Ophthalmology journals focusing on retinal diseases. He is a member of the Mexican Society of Ophthalmology, the Pan-American Association of Ophthalmology, the American Academy of Ophthalmology (AAO), the Association for Research in Vision and Ophthalmology (ARVO), the Mexican Retina Society and the American Society of Retina Specialists (ASRS). He was honored as the 2013 CONACYT fellow abroad, the Gillingham Pan-American Fellow and was granted the 2013 Leonard Ellen Ocular Pathology Fellowship award, 2016 ASRS Honor Award and the 2019 ASRS Senior Honor Award.

Carlos received his medical degree from the Autonomous University of Coahuila and completed his residency in Ophthalmology and Vitreoretinal Surgery Fellowship at the Instituto de Oftalmologia Fundacion “Conde de Valenciana” in Mexico City. He then completed an Ocular Pathology Research Fellowship at McGill University in Montreal, Canada and a research fellowship in retinal diseases and vitreoretinal surgery with the California Retina Consultants and Research Foundation in Santa Barbara, CA.

Panel Information

Thursday, September 2

1:45 PM EST

Spotlight-Latina Representation in STEM & Health Fields

Lead, Inspire, Mentor -- Latinas in science, technology, engineering, and mathematics (STEM) are leading the way for the next generation of scientists who will cure cancer, innovate technological integrations, discover and engineer with sustainability in mind, and solve the challenging problems of tomorrow. Let's join efforts to inspire and mentor more Latinxs to accelerate representation in the STEM and health professions.

Register for this Event